Page 3 - Les meilleurs doctors traitant la maladie suivante : Cancer du larynx - TOP -85 des médecins

Spécialisé en oncologie médicale avec un accent sur le cancer du larynx – traite les patients au complexe hospitalier Medical Park Antalya.

• Formé à la faculté de médecine de l'Université d'Akdeniz
• Plus de 8 ans d'expérience dédiée en oncologie
• Membre de l'équipe spécialisée en oncologie de Medical Park Antalya

Le Dr Ercan Ozden est spécialisé en oncologie médicale, avec une vaste expérience dans le traitement du cancer du larynx et l'amélioration des résultats pour les patients.

• Plus de 20 ans d'expérience en médecine interne et en oncologie
• Spécialisation en oncologie médicale obtenue à la faculté de médecine de l'université de Kocaeli
• Expert en planification de traitements complets pour les tumeurs malignes du larynx
• Parle couramment l'anglais et le turc, assurant une communication claire avec les patients internationaux

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le professeur Kyzas est un expert de premier plan dans le domaine du cancer de la tête et du cou, avec plus de 70 publications citées et plus de 6 000 citations.

• Se former dans des hôpitaux prestigieux du Royaume-Uni en chirurgie orale et maxillo-faciale
• Se spécialiser dans le transfert de tissus libres microvasculaires et la chirurgie reconstructive imprimée en 3D
• Directeur clinique de tous les services de cancérologie à l'ELHT, au service de plus d'un million de personnes
• Chercheur principal pour des essais internationaux sur la résection au laser dans le cancer de la tête et du cou
• Recevoir le prestigieux Bronze National Clinical Excellence Award

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Le Dr Karatas apporte une vaste formation internationale en oto-rhino-laryngologie et en chirurgie de la tête et du cou, avec des spécialisations effectuées à travers l'Europe et les États-Unis.

• Formation dans des institutions prestigieuses telles que l'école de médecine de Hanovre et l'université d'État de l'Ohio
• Membre de plusieurs sociétés professionnelles, dont l'American Academy of Otolaryngology
• Spécialisation dans les techniques chirurgicales avancées pour les cancers de la tête et du cou
• Travail à l'hôpital universitaire Atlas avec une concentration sur les cas complexes

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le professeur Young Ik Son se spécialise exclusivement en oncologie ORL au Samsung Medical Center.

• Professeur d'oto-rhino-laryngologie spécialisé dans le cancer du larynx
• Affilié au Samsung Medical Center – un hôpital de premier plan en Corée du Sud
• Vaste expérience dans le traitement des cas laryngés complexes

Thomas Shpitzer est un oto-rhino-laryngologiste au centre médical Assuta, spécialisé dans les pathologies de la tête et du cou.

• Se concentrer sur les cas d'oncologie en oto-rhino-laryngologie
• Traiter les cancers de la gorge et du larynx
• Faire partie d'une équipe spécialisée dans un grand hôpital privé

Le professeur Ziv Gil dirige l'ensemble du département d'oto-rhino-laryngologie et de chirurgie cervico-faciale du célèbre centre médical Rambam en Israël.

• Chirurgien expérimenté spécialisé dans les cancers complexes de la tête et du cou
• Titulaire du prestigieux titre académique de professeur
• Expert dans la prise en charge des cas avancés de cancer du larynx
• Directeur d'un important département d'hôpital universitaire avec des équipes de spécialistes complètes

Le Prof. Dr Ismet Aslan est spécialisé dans les cancers de la tête et du cou, avec une vaste expérience de recherche et de pratique dans le traitement du cancer du larynx.

• Membre de l'Association turque de laryngologie et d'autres groupes professionnels d'ORL
• Publication de plus de 10 articles de recherche internationaux sur les pathologies ORL
• Plus de 30 ans d'expérience médicale dans le domaine de l'ORL
• Formation avancée suivie à l'Université d'Istanbul